NoFact VIII Deficient Plasma
510(k) K102851Ref 68-201
Active
Valid until
No date given
FDA recalls
None found
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| European Union | CE/IVDD EUDAMED | NumberB-10859394006153 10859394006153 | Date20 May 2026 | StatusActive |
| United States | GUDID listing GUDID | Number10859394006153 | Date15 Nov 2016 | StatusListed |
| United States | FDA 510(k)SESE 510(k) | NumberK102851 | Date19 Dec 2011 | StatusActive |
Official records
- EUDAMED public site B-10859394006153
- AccessGUDID record 10859394006153
- FDA 510(k) database K102851
Across registries
- EUDAMED Basic UDI-DI B-10859394006153 registered 20 May 2026 Active
- FDA 510(k) K102851 decided 19 Dec 2011 Active
- FDA GUDID UDI-DI 10859394006153 listed 15 Nov 2016 Listed
Timeline
- Cleared FDA 510(k) K102851
- Listed FDA GUDID 10859394006153
- Registered EUDAMED B-10859394006153
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
- European Union
- United States
Specification
- Full name
- Nofact VIII
- Generic name
- Coagulation factor VIII IVD, kit, clotting
- Model / Ref / Catalog
- 68-201
- FDA applicant
- R2 Diagnostics, Inc.
- Primary DI / UDI-DI
- 10859394006153
- Basic UDI-DI
- B-10859394006153
- 510(k) Number
- FDA product code
- GJT
- EMDN code
- W0103020207 Coagulation factor VIII
- GMDN term
- Coagulation factor VIII IVD, kit, clotting
- Device class
- Class IVD General EUDAMEDClass II 510(k)GUDID
- Regulation
- 21 CFR Part 864.7290
- EU registration type
- Legacy device (under a directive)
- EU market of registration
- Italy
- Advisory committee
- Hematology
- FDA decision
- SESE Substantially Equivalent
- GUDID distribution status
- In Commercial Distribution
Truth per registry
| Field | EUDAMED | 510(k) | GUDID |
|---|---|---|---|
| Device class | Class IVD General | Class II | Class II |
Overview
AI-generated summary, 18 Sep 2026
NoFact VIII Deficient Plasma is a human plasma substrate immunodepleted of Factor VIII, classified as a Plasma, Coagulation Factor Deficient device under the FDA nomenclature. It is designed for the quantitative determination of Factor VIII activity in citrated patient plasma, utilising an activated partial thromboplastin time assay to measure clotting factor levels in suspected FVIII deficiency cases.
This device is supplied as a single-use, in vitro diagnostic reagent intended for laboratory use. It is authorised under FDA 510(k) clearance and IVDD compliance, with a product code of GJT and device class II classification. Sterility and storage conditions are not specified in the provided data, but it is intended for use in hematology settings where precise coagulation factor measurement is required.
Devices cleared under K102851
Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.
| UDI-DI | Size and differences | |||
|---|---|---|---|---|
| NoFact VIII 68-201 | 68-201 / 68-201 | 10859394006153 | — | On the market |
Similar devices in this category
Other devices filed under COAGULATION FACTOR VIII.
- Factor VIII DP native 5154016 by Technoclone Herstellung von Diagnostika und Arzneimitteln GmbH
- Coagulation Factor VIII Deficient Plasma 10873880 by SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS LTD
- Factor VIII DP native 5154007 by Technoclone Herstellung von Diagnostika und Arzneimitteln GmbH
- TriniCHROM Factor VIII:c T2608 by Tcoag ireland ltd
- HemosIL Factor VIII deficient plasma 0020012800 by INSTRUMENTATION LABORATORY COMPANY
- STA® - Deficient VIII 00725 by DIAGNOSTICA STAGO
- Factor VIII Chromogenic Assay 10445729 B4238-40 by SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS LTD
- TriniCLOT Factor VIII T1508 by Tcoag ireland ltd
- HemosIL Factor VIII deficient plasma 0020011800 by INSTRUMENTATION LABORATORY COMPANY